Ceres Ventures ROE 2010-2011 | CEVE

Current and historical return on equity (ROE) values for Ceres Ventures (CEVE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Ceres Ventures ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2011-09-30 $0.00B $0.00B 0.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-09-30 $0.00B $0.00B -1200.00%
2010-06-30 $0.00B $0.00B -600.00%
2010-03-31 $0.00B $0.00B -400.00%
2009-12-31 $0.00B $0.00B -100.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.000B
Ceres Ventures, Inc. is an investment company. The company does not have any significant operation. Ceres Ventures, Inc., formerly known as PhytoMedical Technologies Inc., is based in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.927B 19.64
Encompass Health (EHC) United States $11.673B 24.77
DaVita (DVA) United States $10.879B 14.44
Chemed (CHE) United States $8.411B 26.43
Option Care Health (OPCH) United States $5.041B 22.40
Elanco Animal Health (ELAN) United States $4.836B 10.70
RadNet (RDNT) United States $3.906B 82.65
Amedisys (AMED) United States $3.109B 20.91
LifeStance Health (LFST) United States $2.551B 0.00
Addus HomeCare (ADUS) United States $1.893B 21.66
Astrana Health (ASTH) United States $1.747B 35.00
U.S Physical Therapy (USPH) United States $1.088B 27.75
Aveanna Healthcare Holdings (AVAH) United States $0.899B 0.00
Pennant (PNTG) United States $0.897B 35.86
Atai Life Sciences (ATAI) Germany $0.282B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00